Not Cleared Direct

DEN230090 - First To Know Syphilis Test (FDA 510(k) Clearance)

Aug 2024
Decision
233d
Days
Class 2
Risk

DEN230090 is an FDA 510(k) submission for the First To Know Syphilis Test. This device is classified as a Test For Detection Of Antibodies Associated With Syphilis Performed By Lay Users (Class II - Special Controls, product code SBZ).

Submitted by Nowdiagnostics (Springdale, US). The FDA issued a Not Cleared (DENG) decision on August 16, 2024.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3986. Test For Detection Of Antibodies Associated With Syphilis Performed By Lay Users Is An In Vitro Diagnostic Device Used For Detection Of Antibodies In Clinical Specimens For Use In Home Settings, Or Similar Environments. The Device Is Intended To Aid In Diagnosis Of Syphilis And Intended For Prescription Use Or Over-the-counter Use..

Submission Details

510(k) Number DEN230090 FDA.gov
FDA Decision Not Cleared Not Substantially Equivalent (DENG)
Date Received December 27, 2023
Decision Date August 16, 2024
Days to Decision 233 days
Submission Type Direct
Review Panel Microbiology (MI)
Summary -

Device Classification

Product Code SBZ - Test For Detection Of Antibodies Associated With Syphilis Performed By Lay Users
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3986
Definition Test For Detection Of Antibodies Associated With Syphilis Performed By Lay Users Is An In Vitro Diagnostic Device Used For Detection Of Antibodies In Clinical Specimens For Use In Home Settings, Or Similar Environments. The Device Is Intended To Aid In Diagnosis Of Syphilis And Intended For Prescription Use Or Over-the-counter Use.